Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(20%)
Terminated
1(20%)

Phase Distribution

Ph phase_2
1
20%
Ph early_phase_1
1
20%
Ph not_applicable
3
60%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(1)
Other(2)

Detailed Status

Suspended2
Terminated1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (20.0%)
Phase 21 (20.0%)
N/A3 (60.0%)

Trials by Status

terminated120%
not_yet_recruiting120%
recruiting120%
suspended240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5